Interleukin/NN
1beta/NN
mediates/VBZ
the/DT
modulatory/JJ
effects/NNS
of/IN
monocytes/NNS
on/IN
LNCaP/NN
human/JJ
prostate/NN
cancer/NN
cells/NNS
./.

Proliferative/JJ
and/CC
secretory/JJ
responses/NNS
in/IN
androgen-sensitive/JJ
prostate/NN
cancer/NN
LNCaP/NN
cells/NNS
are/VBP
regulated/VBN
by/IN
steroid/NN
and/CC
peptide/NN
hormones/NNS
and/CC
by/IN
differentiation-promoting/JJ
substances/NNS
./.
=====
In/IN
the/DT
present/JJ
study/NN
,/,
we/PRP
evaluated/VBD
whether/IN
peripheral/JJ
blood/NN
monocytes/NNS
that/WDT
exhibit/VBP
anti-tumour/JJ
activity/NN
in/IN
haematopoietic/JJ
and/CC
solid/JJ
tumours/NNS
influence/VBP
growth/NN
and/CC
secretion/NN
in/IN
the/DT
LNCaP/NN
cell/NN
line/NN
./.
=====
For/IN
this/DT
purpose/NN
,/,
LNCaP/NN
cells/NNS
were/VBD
incubated/VBN
with/IN
monocyte-conditioned/JJ
medium/NN
(/(
MCM/NN
)/)
,/,
and/CC
proliferation/NN
as/RB
well/RB
as/IN
expression/NN
of/IN
androgen/NN
receptor/NN
(/(
AR/NN
)/)
and/CC
secretion/NN
of/IN
prostate-specific/JJ
antigen/NN
(/(
PSA/NN
)/)
were/VBD
assessed/VBN
./.
=====
Conditioned/JJ
medium/NN
from/IN
monocytes/NNS
reduced/VBD
proliferation/NN
in/IN
a/DT
dose-dependent/JJ
manner/NN
./.
=====
Incubation/NN
with/IN
40/CD
%/NN
MCM/NN
caused/VBD
a/DT
50/CD
%/NN
reduction/NN
in/IN
cell/NN
proliferation/NN
./.
=====
AR/NN
protein/NN
decreased/VBD
by/IN
70/CD
%/NN
and/CC
PSA/NN
levels/NNS
in/IN
supernatants/NNS
from/IN
LNCaP/NN
cells/NNS
were/VBD
reduced/VBN
by/IN
approximately/RB
80/CD
%/NN
following/VBG
treatment/NN
with/IN
MCM/NN
./.
=====
We/PRP
focused/VBD
on/IN
the/DT
contribution/NN
of/IN
two/CD
major/JJ
products/NNS
of/IN
activated/VBN
monocytes/NNS
,/,
prostaglandin/NN
E2/NN
and/CC
interleukin/NN
1beta/NN
(/(
IL-1beta/NN
)/)
,/,
to/TO
the/DT
MCM/NN
modulatory/JJ
action/NN
./.
=====
LNCaP/NN
cells/NNS
treated/VBN
with/IN
prostaglandin/NN
E2/NN
showed/VBD
neither/CC
a/DT
reduction/NN
in/IN
proliferation/NN
nor/CC
a/DT
down-regulation/NN
of/IN
AR/NN
and/CC
PSA/NN
levels/NNS
./.
=====
The/DT
effects/NNS
of/IN
MCM/NN
on/IN
cellular/JJ
proliferation/NN
,/,
AR/NN
protein/NN
and/CC
PSA/NN
secretion/NN
were/VBD
abolished/VBN
by/IN
pretreatment/NN
of/IN
MCM/NN
with/IN
a/DT
neutralizing/VBG
anti-IL-1beta/NN
antibody/NN
./.
=====
In/IN
addition/NN
,/,
recombinant/JJ
IL-1beta/NN
was/VBD
able/JJ
to/TO
replace/VB
MCM/NN
for/IN
the/DT
inhibition/NN
of/IN
proliferation/NN
and/CC
down-regulation/NN
of/IN
AR/NN
and/CC
PSA/NN
proteins/NNS
./.
=====
LNCaP/NN
cells/NNS
were/VBD
shown/VBN
to/TO
express/VB
the/DT
IL-1beta/NN
receptor/NN
type/NN
1/CD
,/,
which/WDT
transduces/VBZ
IL-1beta/NN
signal/NN
./.
=====
Our/PRP$
findings/NNS
reveal/VBP
that/IN
monocyte-derived/JJ
IL-1beta/NN
inhibits/VBZ
the/DT
proliferation/NN
of/IN
androgen-responsive/JJ
prostate/NN
tumour/NN
cells/NNS
and/CC
reduces/VBZ
AR/NN
and/CC
PSA/NN
levels/NNS
./.